Greenwich LifeSciences, Inc.
GLSI Healthcare Biotechnology
In the quarter to June 2026, EPS grew 10.0% and free cash flow grew 13.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow GLSI
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
0.00 | 0.09 | 0.01 | 28.66 | 27.20 | 13.47 | 6.99 | 4.09 | 6.18 |
Total current assets |
0.00 | 0.09 | 0.01 | 28.66 | 27.20 | 13.47 | 6.99 | 4.09 | 6.18 |
Goodwill and Intangible Assets (Total) |
0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | — |
Total non-current assets |
— | — | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | — |
Total Assets |
— | 0.11 | 0.03 | 28.68 | 27.22 | 13.48 | 6.99 | 4.09 | 6.18 |
Accounts Payable |
0.16 | 0.28 | 0.73 | 0.71 | 0.22 | 0.22 | 0.26 | 2.80 | 4.87 |
Current Revenue (Deferred) |
— | — | — | — | — | — | — | 0.31 | 0.67 |
Other current liabilities |
0.40 | 0.45 | 0.65 | 0.33 | 0.16 | 0.04 | 0.04 | 0.08 | 0.28 |
Total current liabilities |
0.56 | 0.73 | 1.38 | 1.05 | 0.39 | 0.26 | 0.29 | 3.19 | 5.82 |
Total liabilities |
8.56 | 10.23 | 1.38 | 1.05 | 0.39 | 0.26 | 0.29 | 3.19 | 5.82 |
Additional Paid In Capital |
— | — | 25.85 | 56.70 | 60.47 | 54.67 | 57.05 | 68.67 | 87.48 |
Preferred Stock (Total) |
— | — | 0.00 | — | — | — | — | — | — |
Common Stock (Net) |
0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Retained Earnings |
(22.10) | (23.79) | (27.21) | (29.08) | (33.65) | (41.47) | (50.36) | (67.78) | (87.14) |
Common Equity (Total) |
(8.54) | (10.13) | (1.35) | 27.63 | 26.83 | 13.21 | 6.70 | 0.91 | 0.35 |
Shareholders Equity (Total) |
(8.53) | (10.12) | (1.35) | 27.63 | 26.83 | 13.21 | 6.70 | 0.91 | 0.35 |
Shareholders Equity and Liabilities (Total) |
— | — | 0.03 | 28.68 | 27.22 | 13.48 | 6.99 | 4.09 | 6.18 |
Shares (Common) |
— | — | 8.46 | 12.70 | 13.15 | 12.85 | 12.85 | 13.15 | 14.30 |
Shares (Preferred) |
— | — | 1.98 | — | — | — | — | — | — |
Shareholders Equity (Tangible) |
— | — | (1.37) | 27.61 | 26.82 | 13.21 | 6.70 | 0.91 | 0.35 |
Net Debt |
0.00 | (0.09) | (0.01) | (28.66) | (27.20) | (13.47) | (6.99) | (4.09) | (6.18) |
| Other line items | |||||||||
Non-current Liabilities (Other) |
8.00 | 9.50 | — | — | — | — | — | — | — |